Enrique Espinosa - Department of Oncology|Hospital La Paz

基本信息

浏览量：65

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 278 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors

Álvaro Pinto, Jesús Miranda,Ana Pertejo,Mario Álvarez-Maestro,Pilar González-Peramato, Alfredo Aguilera, Eugenia García, Lucía Trilla, Ángelo Gámez,Enrique Espinosa

Clinical and Translational Oncologyno. 2 (2024): 532-537

引用0浏览0WOS引用

Supplementary Table S6 from Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Angelo Gámez-Pozo, Julia Berges-Soria,Jorge M. Arevalillo,Paolo Nanni,Rocío López-Vacas,Hilario Navarro,Jonas Grossmann,Carlos A. Castaneda,Paloma Main,Mariana Díaz-Almirón,Enrique Espinosa,Eva Ciruelos,

crossref（2023）

引用0浏览0引用

Supplementary Table S4 from Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

crossref（2023）

引用35浏览0引用

243P Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in metastatic breast cancer patients

Javier Álvarez Criado, Víctor Manuel Fernández Martínez, M.P. Zamora Aunon,Jesús Peña-López,Violeta Sánchez,Enrique Espinosa, Ángela Hoyo-Muñoz, Laura García‐López, C. Mateos-Salillas,D. Martinez Perez,Beatriz Castelo,Iciar Ruiz-Gutierrez,

ESMO Openno. 1 (2023): 101431-101431

引用0浏览0引用

Supplementary Table S8 from Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Angelo Gámez-Pozo,Julia Berges-Soria,Jorge M. Arevalillo,Paolo Nanni,Rocío López-Vacas,Hilario Navarro,Jonas Grossmann,Carlos A. Castaneda,Paloma Main,Mariana Díaz-Almirón,Enrique Espinosa,Eva Ciruelos,

crossref（2023）

引用0浏览0引用

Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma

Lucia Trilla-Fuertes,Angelo Gamez-Pozo,Guillermo Prado-Vazquez,Rocio Lopez-Vacas,Andrea Zapater-Moros,Elena Lopez-Camacho,Maria Lumbreras-Herrera,Virtudes Soriano,Fernando Garicano, Ma Jose Lecumberri,Maria Rodriguez de la Borbolla,Margarita Majem,

Int J Mol Sci（2023）

引用0浏览0WOS引用

Palbociclib Rechallenge for Hormone Receptor-Positive/HER-Negative Advanced Breast Cancer: Findings from the Phase II BioPER Trial

Joan Albanell,José Manuel Pérez-García,Miguel Gil-Gil,Giuseppe Curigliano,Manuel Ruíz-Borrego,Laura Comerma,Joan Gibert,Meritxell Bellet,Begoña Bermejo,Lourdes Calvo,Juan de la Haba,Enrique Espinosa,

Clin Cancer Res（2023）

引用10浏览0WOS引用

Supplementary Table S2 from Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

Angelo Gámez-Pozo,Julia Berges-Soria,Jorge M. Arevalillo,Paolo Nanni,Rocío López-Vacas,Hilario Navarro,Jonas Grossmann,Carlos A. Castaneda,Paloma Main,Mariana Díaz-Almirón,Enrique Espinosa,Eva Ciruelos,

crossref（2023）

引用0浏览0引用

Predicting Risk of Severe Toxicity and Early Death in Older Adult Patients Treated with Chemotherapy

Jaime Feliu,Ana Belen Custodio,Alvaro Pinto-Marin,Oliver Higuera, Miriam Perez-Gonzalez, Laura del Pino, Leticia Ruiz-Jimenez, Dario Sanchez-Cabero, Isabel Viera, Ana Jurado,Enrique Espinosa

CANCERSno. 18 (2023): 4670-4670

引用0浏览0WOS引用

Multi-omics Characterization of Response to PD-1 Inhibitors in Advanced Melanoma

Lucía Trilla-Fuertes,Angelo Gámez-Pozo,Guillermo Prado-Vázquez,Rocío López-Vacas,Virtudes Soriano,Fernando Garicano, M José Lecumberri,María Rodríguez de la Borbolla,Margarita Majem,Elisabeth Pérez-Ruiz,María González-Cao,Juana Oramas,

Cancers（2023）

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn